# The Evidence Based Rheumatology Podcast

Page: https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175
Text version: https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175.md
RSS feed: https://feed.podbean.com/msputman/feed.xml
Official site: https://msputman.podbean.com
Author: Michael Putman
Episodes: 100

## Resource

A podcast for physicians about evidence based medicine in rheumatology. Each week we'll critique and apply a paper in the medical literature.

## Machine-readable

JSON: https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175
Markdown: https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175.md

## Episodes
- [E138: Dapirolizumab for SLE (PHOENYCS-GO)](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e138-dapirolizumab-for-sle-phoenycs-go) — 2026-07-24T20:33:26+00:00
- [E137: Obexelimab in IgG4-RD (INDIGO)](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e137-obexelimab-in-igg4-rd-indigo) — 2026-06-29T19:14:56+00:00
- [E136: Secukinumab in PMR (REPLENISH)](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e136-secukinumab-in-pmr-replenish) — 2026-06-15T14:12:00+00:00
- [E135: IL17 and a GLP1?](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e135-il17-and-a-glp1) — 2026-04-30T13:43:00+00:00
- [E134: Brepocitinib in Dermatomyositis (VALOR)](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e134-brepocitinib-in-dermatomyositis-valor) — 2026-04-17T20:06:48+00:00
- [E133: Obinutuzumab for SLE (ALLEGORY)](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e133-obinutuzumab-for-sle-allegory) — 2026-03-19T19:32:38+00:00
- [E132: Romosozumab vs teriparatide for osteoproosis (STRUCTURE)](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e132-romosozumab-vs-teriparatide-for-osteoproosis-structure) — 2026-03-05T15:54:58+00:00
- [E131: A Sham-Controlled Sham of a Trial: RESET-RA](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e131-a-sham-controlled-sham-of-a-trial-reset-ra) — 2026-01-21T18:05:16+00:00
- [E130: Telitacicept for SLE](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e130-telitacicept-for-sle) — 2025-12-22T23:07:00+00:00
- [E129: Long Term Routine Laboratory Monitoring in RA](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e129-long-term-routine-laboratory-monitoring-in-ra) — 2025-12-04T13:02:00+00:00
- [E128: Nerandomilast for Autoimmune ILD (FIBRONEER-ILD)](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e128-nerandomilast-for-autoimmune-ild-fibroneer-ild) — 2025-11-12T18:07:48+00:00
- [E127: TNFs and All That CHF](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e127-tnfs-and-all-that-chf) — 2025-09-22T18:22:00+00:00
- [E126: Risk Signals, JAKs, and SELECTIVE-ity](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e126-risk-signals-jaks-and-selective-ity) — 2025-09-08T17:45:15+00:00
- [E125: Adrenal Insufficiency after Stopping Prednisone](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e125-adrenal-insufficiency-after-stopping-prednisone) — 2025-06-29T20:52:00+00:00
- [e124: MTX vs Pred for Pulmonary Sarcoidosis: PREDMETH Study](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e124-mtx-vs-pred-for-pulmonary-sarcoidosis-predmeth-study) — 2025-06-12T16:27:43+00:00
- [E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e123-upadacitinib-for-giant-cell-arteritis-select-gca) — 2025-04-30T15:33:13+00:00
- [E122: Guidelines for Maybe Diagnosing HLH](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e122-guidelines-for-maybe-diagnosing-hlh) — 2025-04-17T17:26:00+00:00
- [E121: Obinutuzumab in SLE-LN](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e121-obinutuzumab-in-sle-ln) — 2025-04-02T17:07:44+00:00
- [E120: Real Life Use of PEXIVAS-Low](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e120-real-life-use-of-pexivas-low) — 2025-03-06T17:00:14+00:00
- [E119: Teclistamab for Rheumatology Writ Large](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e119-teclistamab-for-rheumatology-writ-large) — 2025-02-10T16:55:00+00:00
- [E118: The emerging risk of overdiagnosis in RA and PMR](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e118-the-emerging-risk-of-overdiagnosis-in-ra-and-pmr) — 2025-01-31T15:42:47+00:00
- [E117: Inebilizumab for IgG4-RD (MITIGATE)](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e117-inebilizumab-for-igg4-rd-mitigate) — 2024-12-03T16:55:35+00:00
- [E116: A New Paradigm for PMR](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e116-a-new-paradigm-for-pmr) — 2024-11-11T19:32:00+00:00
- [E115: Benralizumab for EGPA - the MANDARA Study](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e115-benralizumab-for-egpa-the-mandara-study) — 2024-10-28T18:31:00+00:00
- [E114: Target Trials and STAR-RA with Rishi Desai](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e114-target-trials-and-star-ra-with-rishi-desai) — 2024-10-14T18:26:00+00:00

## Actions

Episode pages expose an explicit `request_transcript` action. A page view does not automatically enqueue transcription.